Makoto Yamada

Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501)

Masanori Terashima, Yoshiaki Iwasaki, Junki Mizusawa et al. · Gastric Cancer · 2019 · 127 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Large Type 3 +8

Solid–papillary carcinoma of the breast: Clinicopathological study of 20 cases

Yoshiro Otsuki, Makoto Yamada, Shinichi Shimizu et al. · Pathology International · 2007 · 80 citations

Surgical Oncology, Breast Oncology, Mucinous Carcinoma +12

Age-related variations in global spinal alignment and sagittal balance in asymptomatic Japanese adults

Kunio Yokoyama, Masahiro Kawanishi, Makoto Yamada et al. · Neurological Research · 2017 · 70 citations

Fetuin‐A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects

Motoya Sato, Yoshihiro Kamada, Yuri Takeda et al. · Liver International · 2014 · 66 citations

Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis

Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo et al. · Hepatology Communications · 2017 · 48 citations · Full text